Urgent product defect correction– Notice from the TGA - ENDONE oxycodone hydrochloride 5mg tablet blister pack 

A single report has been received from a consumer in South Australia indicating that a strip of 30mg Anamorph tablets was allegedly present in a box of 5mg Endone, post dispensing.  
The Anamorph tablets are approximately four times the Endone equivalent dose, so there is a theoretical potential for overdose, particularly if taken by an opioid naïve patient. 
This action supersedes the quarantine notice issued 26 July 2019. 
This action supersedes the retail level quarantine notice issued 26 July 2019.

Further information is available on the TGA website at: https://www.tga.gov.au/alert/endone-5-mg-tablets  

Therapeutic Goods Administration Notice



Beckwith Park, 30 Tanunda Road Nuriootpa SA 5355
PO Box 868 Nuriootpa SA 5355
T 08 8565 8900 F 08 8311 1723
E This email address is being protected from spambots. You need JavaScript enabled to view it.





While the Australian Government Department of Health has contributed to the funding of this website, the information on this website does not necessarily reflect the views of the Australian Government and is not advice that is provided, or information that is endorsed, by the Australian Government. The Australian Government is not responsible in negligence or otherwise for any injury, loss or damage however arising from the use of or reliance on the information provided on this website.

Country SA PHN gratefully acknowledge the financial and other support from the Australian Government Department of Health